Antisense Molecules Targeting Staphylococcus aureus Membrane Stability Proteins
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current treatments for Staphylococcus aureus infections, particularly methicillin-resistant strains, are inadequate in effectively inhibiting bacterial growth and do not adequately target membrane stability proteins without causing toxicity.
Innovation Solution
Development of antisense molecules targeting Staphylococcus aureus membrane stability proteins using natural and non-natural nucleic acid polymers, specifically peptide nucleic acids (PNAs) conjugated with cell-penetrating peptides, which hybridize to the bacterial DNA and inhibit gene expression, while being designed to avoid FmhB protein.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If conventional treatments are used for Staphylococcus aureus infections, then bacterial growth inhibition is achieved, but toxicity increases and effectiveness against methicillin-resistant strains decreases
Solution Approach 1:
The treatment approach is segmented into two distinct components: a nonspecific cationic polymer for general antibacterial activity and a specific antisense oligonucleotide for targeted gene inhibition. This segmentation allows each component to perform its specialized function, improving overall effectiveness while reducing the dosage and toxicity of individual agents
Solution Approach 2:
The invention uses a composite system combining a cationic polymer (such as polylysine or chitosan) with antisense oligonucleotides. This composite material leverages the membrane-disrupting properties of cationic polymers and the sequence-specific inhibition of antisense oligos, achieving enhanced antibacterial activity against resistant strains with reduced toxicity compared to conventional monotherapies
2Reliability
If antisense molecules are designed to target membrane stability proteins, then gene expression inhibition improves, but risk of off-target effects increases
Solution Approach 1:
The cationic polymer acts as an intermediary carrier that delivers the antisense oligonucleotide to the bacterial cell. The polymer's nonspecific membrane interaction facilitates cellular uptake while the antisense oligonucleotide provides sequence-specific targeting, thereby improving gene inhibition efficiency while minimizing off-target effects through precise molecular recognition
Solution Approach 2:
The antisense oligonucleotide is designed with specific parameter optimizations including length (15-50 nucleotides), GC content (40-60%), and melting temperature (50-70°C) to ensure high-affinity binding to the target membrane stability protein mRNA. These parameter adjustments enhance binding specificity and strength, improving gene expression inhibition while reducing the likelihood of off-target hybridization
3Productivity
If cell penetration molecules are conjugated to antisense molecules, then delivery efficiency improves, but molecular complexity increases
Solution Approach 1:
The cationic polymer and antisense oligonucleotide are combined into a single conjugate molecule through covalent bonding or noncovalent complexation. This merging integrates the cell-penetration capability of the polymer with the gene-inhibition function of the oligonucleotide, improving delivery efficiency while maintaining relatively simple molecular structures that can be synthesized using standard chemical techniques
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The antisense molecules effectively inhibit Staphylococcus aureus growth in vitro and in vivo, demonstrating significant bactericidal activity with low toxicity, as shown by MRSA growth inhibition and safety studies in mice models, reducing bacterial burden in blood infections.
Implementation Method 1
comprising a polynucleotide sequence that is antisense to the coding region of a Staphylococcus aureus membrane stability protein and hybridizes to said coding region under physiological conditions
Data Source
Figure 1
Figure 2A~2B
Figure 3
AI summary
Disclosed are antisense molecules and compositions for the treatment of Staphylococcus aureus infection. The antisense molecules and compositions comprise nucleic acid molecules, such as RNA, DNA, or nucleic acid molecules with modified backbones, such as PNA. The antisense molecules and compositions inhibit expression of membrane stability proteins in Staphylococcus aureus; are optionally conjugated to cell penetration molecules such as peptides; and are optionally administered in the form of a nanoparticle composition.